
Not yet open for enrollment. The study is undergoing scientific review before its research plan is finalized.
Please check this page for updates about eligibility and how to be considered when enrollment opens.
About the Study
NIH is developing a research study to better understand serious health problems reported after vaccination with a focus on the genetics and immunological basis of these problems. The MOSAIC Study will operate through research enrollment and scheduled study visits that will take place in Bethesda, MD. It will not accept walk-in patients or offer routine appointments to the general public.
Where We Are in the Process
Enrollment has not begun. The study is currently undergoing scientific review before its research plan, called a protocol, is finalized. A protocol describes the study's purpose, who can participate, what participation involves, and how participants will be protected. These requirements help protect participants and ensure the study can answer its research questions.
Study initiation depends on completion of the following development and review requirements. Timing remains subject to change based on the reviews and any iterative revisions or additional information requested during the process. (See the glossary for an explanation of these terms).
- Concept development and early review
- Protocol drafting
- Scientific review
- Regulatory review
- NIH Clinical Center review, which is required for all intramural protocols
- Institutional Review Board (IRB) submission and review, including follow-up on any items requested by the IRB
- Data Safety and Monitoring Board review
Scientific review is currently underway. NIAID and Clinical Center staff are working expeditiously to complete the remaining requirements so the study can begin. We will update this page as the study moves through the review process and information becomes available.
Who Can Participate
Eligibility requirements will be shared when enrollment opens. Each clinical study has specific requirements to help protect participants and ensure the research can answer its questions.
Expressing interest in participating in the trial does not guarantee eligibility or enrollment.
How Can I Stay Informed
Please check this page for updates. When enrollment opens, this page and the study's ClinicalTrials.gov entry will be updated with participation information.
For Information, Contact
Email: mosaicstudy@mail.nih.gov
Phone: 833-JOIN-NIH (564-6644)
Telecommunications relay services: Dial 711
Due to the high volume of inquiries, we may not be able to respond to every email individually. If you have already contacted us, we will do our best to notify you by email when enrollment opens.
Learn About Clinical Research
Participation in clinical research is voluntary. Learn about study procedures, informed consent, risks, potential benefits, and participant protections at NIH Clinical Research Trials and You: The Basics.
For background, read the NIH leadership statement about the Vaccinology and Immunology Center as well as the VIC terminology fact sheet.
Department of Health and Human Services
National Institute of Allergy and Infectious Diseases (NIAID)